Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Expensify (EXFY) Research & Development (2020 - 2025)

Expensify (EXFY) has disclosed Research & Development for 6 consecutive years, with $5.3 million as the latest value for Q4 2025.

  • Quarterly Research & Development fell 21.49% to $5.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.7 million through Dec 2025, down 16.05% year-over-year, with the annual reading at $20.7 million for FY2025, 16.05% down from the prior year.
  • Research & Development hit $5.3 million in Q4 2025 for Expensify, up from $4.9 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $6.7 million in Q4 2024 to a low of $1.1 million in Q1 2021.
  • Historically, Research & Development has averaged $4.7 million across 5 years, with a median of $5.1 million in 2023.
  • Biggest YoY gain for Research & Development was 237.37% in 2022; the steepest drop was 26.47% in 2022.
  • Year by year, Research & Development stood at $2.8 million in 2021, then grew by 4.95% to $3.0 million in 2022, then soared by 108.93% to $6.2 million in 2023, then increased by 7.25% to $6.7 million in 2024, then dropped by 21.49% to $5.3 million in 2025.
  • Business Quant data shows Research & Development for EXFY at $5.3 million in Q4 2025, $4.9 million in Q3 2025, and $5.2 million in Q2 2025.